Physician profile
Meghan Earley
NPI 1255711859
$2,484.49
in general payments reported to CMS, 2019-2025
12 companies · $345 in 2025
The $345 reported for 2025 was more than what a typical Occupational Vision provider received nationally (typical 2025 total: $169).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $136 · 2021: $588 · 2022: $509 · 2023: $287 · 2024: $480 · 2025: $345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,112.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,112.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,140.57 | 2019-2025 | Centurion, Total30, Precision 7 |
| Johnson & Johnson Vision Care, INC. | $501.16 | 2019-2025 | Acuvue |
| Lkc Technologies, INC. | $146.76 | 2024 | |
| Coopervision INC. | $131.49 | 2023-2025 | Myday Contact Lens, Misight Contact Lens |
| Glaukos Corporation | $129.11 | 2020-2022 | |
| Allergan, INC. | $106.50 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $103.07 | 2025 | |
| Dompe US, INC. | $96.12 | 2024 | Oxervate |
| Sun Pharmaceutical Industries INC. | $51.86 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $34.82 | 2023-2025 | Xiidra, Infuse |
| Abbvie INC. | $23.55 | 2022 | |
| Horizon Therapeutics Plc | $19.48 | 2023 | Tepezza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meghan Earley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.